USPTO serial 78242016
PRIMAGEN
Reviewed by CopyMark Law Group
Reg. 3411657Status 710
- Filing date
- Status date
- Registration date
- Apr 15, 2008
- Examiner
- WEIGLE, KATHERINE CONNOLLY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PRIMAGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
1105 BA Amsterdam, NL
1105 BA Amsterdam, NL
1105 BA Amsterdam, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael B. Lasky
Michael B. Lasky Altera Law Group220 South Sixth Street1700 US Bank Plaza SouthMinneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | molecular diagnostic kits comprised of medical and diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology used to generate a clinical or scientific result by the amplification and/or detection of DNA or RNA sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of HIV and other virus detection, mitochondrial function and/or toxicity, and for tumor marker detection | SECTION 8 - CANCELLED | — |
| 010 | Medical and veterinary diagnostic apparatus and instruments to be used with molecular diagnostic kits used to generate a clinical or scientific result by the amplification and/or detection of DNA or RNA sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of HIV and other virusdetection, mitochondrial function and/or toxicity, and for tumor marker detection | SECTION 8 - CANCELLED | — |
| 042 | Scientific, medical and veterinary research services utilizing medical and diagnostic reagents for in vitro use in the fields of biochemistry, clinical chemistry and microbiology for generating clinical and scientific result by the amplification and/or detection of DNA or RNA sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of HIV and other virus detection, mitochondrial function and/or toxicity, and for tumor marker detection | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PrimaGen Holding B.V.
- Other trademarks owned by PrimaGen Holding B.V.
- Other trademarks owned by PrimaGen Holding B.V.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named PRIMAGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2014 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Apr 15, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 29, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 9, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 22, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 21, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 19, 2007 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Dec 19, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2007 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 19, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 20, 2007 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 20, 2007 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 20, 2007 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 19, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 16, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 16, 2006 | ALIE | ASSIGNED TO LIE | — |
| May 24, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 28, 2005 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 10, 2005 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 25, 2004 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 26, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 26, 2004 | PAPER RECEIVED | — | |
| Sep 28, 2003 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2003 | DOCK | ASSIGNED TO EXAMINER | — |